(paliperidone palmitate)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
INVEGA SUSTENNA® (paliperidone palmitate)
Medical Information
INVEGA SUSTENNA - Administration - General Administration Instructions
Last updated : 11/11/2024
SPECIFIC RESPONSE
Administered ONLY by a health care professional1
Each INVEGA SUSTENNA extended-release injectable suspension is intended for IM use only1
-
DO NOT administer via any other route
-
Avoid inadvertent injection into a blood vessel
-
Administer dose in a single injection; DO NOT administer in divided injections
-
Inject slowly, deep into the muscle
ONLY use needles provided in the INVEGA SUSTENNA kit.1
-
DO NOT substitute these needles with commercially available safety needles as they may have a different dead space volume that may result in the administration of a lower or higher INVEGA SUSTENNA dose.2
HCP, health care provider; IM, intramuscular.
References
Show Hide
1. INVEGA SUSTENNA [(paliperidone palmitate) Extended-Release Injectable Suspension] [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://imedicalknowledge.veevavault.com/ui/approved_viewer?token=7994-54c7ff1c-5e50-4845-a605-24e8c5104cd7.
2. Data on File. Janssen Research & Development. 2014.
